Private and public efforts to sequence the human genome, Ari Patrinos
Interviewee: Ari Patrinos. Ari Patrinos talks about private and public efforts to sequence the human genome.
The positive side of this challenge: we needed a little bit of a kick in the rear to get us going. I mentioned earlier the tensions that existed among the Institutions and even the countries about the details of which chromosome one does, and what are the rules, and what are even some of the trivial rules about data release and sharing, and you know, I think had we not had an external challenge we ultimately would have come together, there was no question about it, but we would have done it in a slower pace.
human genome project,public efforts,interviewee,chromosome,tensions,little bit,slower pace,institutions
Craig Venter, leader of the private effort at Celera Genomics, speaks about the excitement the race to sequence the human genome generated.
Craig Venter, leader of the private effort at Celera Genomics, speaks about his company's reliance on the public data for reassembly of the Celera sequence.
Eric Lander talks about analysis in public and private Human Genome Projects.
Shane Yeager, from the Whitehead Institute Center for Genome Research, explains the processes of storing and preparing DNA for sequencing.
Ari Patrinos, director of the US Department of Energy's sequencing effort, talks about the public genome project's aims that extended beyond those of the private project.
Craig Venter speaks about the public sector's reaction to his plans to sequence the genome at a private company, Celera Genomics.
Nobel Laureate John Sulston, former director of the Wellcome Trust Sanger Institute, talks about the competition within the public sequencing effort, and the distraction of the private.
Jim Kent, the author of the assembly program for the public sequence, talks about the challenge of reassembling the genome.
Jim Kent talks about junk DNA in the human genome.
Ari Patrinos, director of the U.S. Department of Energy's sequencing effort, talks about the private genome project announcement and public funding.